Cerecor Engages SunTrust Robinson Humphrey to Assist with Review of Strategic Alternatives
BALTIMORE, MD--(Marketwired - February 07, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced that …